Genus Plc (GNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Genus plc (Genus) is a global animal genetic company. The company is involved in the application of quantitative genetics and biotechnology to animal breeding primarily in two sectors, namely, bovine and porcine. The primary activities of the company include supply of dairy and beef cattle semen under ABS trademark; supply of pigs and their semen under PIC trade mark; and other value added and technical support services. The key customers of the company include farmers, breeders, processors, distributors, retailers, and consumers. The company has its operations in North America, Latin America, Europe and Far East. It has its research and development (R&D) laboratories in Madison, Wisconsin. Genus is headquartered in Basingstoke, the UK.
Genus Plc Key Recent Developments
Sep 08, 2016: Genus: Preliminary Results for the year ended 30 June 2016 Significant Strategic Progress and Continued Profit Growth Sep 07, 2016: Genus Announces Non-Executive Director Retirement Aug 15, 2016: Genus: Final Jury Decisions in US Litigation Aug 12, 2016: Genus: Further Decisions in US Litigation Mar 04, 2016: Genus announces board of director
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table Of Contents
Genus Plc (GNS) - Financial and Strategic SWOT Analysis Review Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Section 1 - About the Company 6 Genus Plc - Key Facts 6 Genus Plc - Key Employees 7 Genus Plc - Key Employee Biographies 8 Genus Plc - Major Products and Services 9 Genus Plc - History 10 Genus Plc - Company Statement 12 Genus Plc - Locations And Subsidiaries 14 Head Office 14 Other Locations and Subsidiaries 14 Section 2 - Company Analysis 17 Genus Plc - Business Description 17 Genus Plc - Corporate Strategy 18 Genus Plc - SWOT Analysis 19 SWOT Analysis - Overview 19 Genus Plc - Strengths 19 Genus Plc - Weaknesses 20 Genus Plc - Opportunities 21 Genus Plc - Threats 22 Genus Plc - Key Competitors 23 Section 3 - Company Financial Ratios 24 Financial Ratios - Capital Market Ratios 24 Financial Ratios - Annual Ratios 25 Performance Chart 27 Financial Performance 27 Financial Ratios - Interim Ratios 28 Financial Ratios - Ratio Charts 29 Section 4 - Company's Lifesciences Financial Deals and Alliances 30 Genus Plc, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 30 Genus Plc, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 31 Genus Plc, Recent Deals Summary 32 Section 5 - Company's Recent Developments 33 Sep 08, 2016: Genus: Preliminary Results for the year ended 30 June 2016 Significant Strategic Progress and Continued Profit Growth 33 Sep 07, 2016: Genus Announces Non-Executive Director Retirement 34 Aug 15, 2016: Genus: Final Jury Decisions in US Litigation 35 Aug 12, 2016: Genus: Further Decisions in US Litigation 36 Mar 04, 2016: Genus announces board of director 37 Section 6 - Appendix 38 Methodology 38 Ratio Definitions 38 About GlobalData 42 Contact Us 42 Disclaimer 42
List of Tables Genus Plc, Key Facts 6 Genus Plc, Key Employees 7 Genus Plc, Key Employee Biographies 8 Genus Plc, Major Products and Services 9 Genus Plc, History 10 Genus Plc, Subsidiaries 14 Genus Plc, Key Competitors 23 Genus Plc, Ratios based on current share price 24 Genus Plc, Annual Ratios 25 Genus Plc, Interim Ratios 28 Genus Plc, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 30 Genus Plc, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 31 Genus Plc, Recent Deals Summary 32 Currency Codes 38 Capital Market Ratios 38 Equity Ratios 39 Profitability Ratios 39 Cost Ratios 40 Liquidity Ratios 40 Leverage Ratios 41 Efficiency Ratios 41
List of Figures Genus Plc, Performance Chart (2012 - 2016) 27 Genus Plc, Ratio Charts 29 Genus Plc, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 30 Genus Plc, Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 31